Argentina evaluates alternatives to avert Parkinson's drug shortage after Pfizer supply issue

Pfizer reported supply issues for Lebocar, a Parkinson's drug, prompting Argentina's Ministry of Health to announce that a national laboratory will double production while ANMAT assesses further measures. The scope of the shortage and timeline for resolution remain unclear, but the response aims to ensure continued access to treatment.